Functional blood progenitors for mouse and manNature.comBlood research and therapeutics for blood disorders would greatly benefit from a ready source of stem and progenitor cells. Although hematopoietic stem cells (HSCs) have been produced by many rout… Continue reading
Biotech Gene Therapy Names Juno, Kite, And bluebird bio Still Have Room To RunSeeking AlphaThis report highlights a trio of gene therapy names with additional upside for investors with an 18-month time horizon. BLUE should net at least $150,000 per pat… Continue reading
Russia Beyond the Headlines |
Siberian scientists say stem cells can treat varicose veins
Russia Beyond the Headlines “Quite a lot of pathologies regarding veins still remain unstudied,” said Igor Mayborodin, a doctor of medical sciences at the stem cell laboratory at ICBFM. “We’ve looked into blood flow restoration in situations when there are blood clots. Now we’re … |
Pharmaceutical Processing |
Eiger Sells Cardiovascular Gene Therapy to Theragene in $18.1M Deal
Pharmaceutical Processing Eiger BioPharmaceuticals announced an agreement to sell to Theragene Pharmaceuticals, Inc., a private biotechnology company, a non-strategic asset, Mydicar® (rAAV1-SERCA2a). Financial terms of the agreement include a total upfront of $3.1 million in … Eiger sells gene therapy candidate Mydicar to Theragene for $3.1M in cash and stockSeeking Alpha |
|
Can CRISPR Conquer Huntington’s?
PLoS Blogs (blog) I set a high bar for writing about mouse studies. I don’t include them in my textbooks or news articles, and only rarely blog about them. But when experiments in mice shine a glimmer of hope on a horrific illness with a long history of failed … |
PLoS Blogs (blog) |
Can CRISPR Conquer Huntington’s? | DNA Science Blog
PLoS Blogs (blog) I set a high bar for writing about mouse studies. I don’t include them in my textbooks or news articles, and only rarely blog about them. But when experiments in … Gene Editing Reverses Huntington’s in Mouse StudyBioscience Technology |